[1]CurrentPatentAssignee:FLARETHERAPEUTICS-WO2022/187203,2022,A1Locationinpatent:Paragraph00100;00101
[2]CurrentPatentAssignee:FLARETHERAPEUTICS-WO2022/187203,2022,A1Locationinpatent:Paragraph00100;00101
1193162-21-8
1378875-92-3
1504876-00-9
1807244-07-0
206551-41-9
334792-52-8
1150703-55-1 | 1-(3-Fluorobenzyl)-5-methyl-1h-1,2,3-triazole-4-carboxylic acid | AA000FRR | MFCD17964756
115615-02-6 | 4-(Cyanomethyl)-2h-1,4-benzoxazin-3(4h)-one | AA000G6M | MFCD00268751
1153042-94-4 | 1-(2-Bromophenyl)-3-(trifluoromethyl)-1H-pyrazol-5-ol | AA000GI2 | MFCD13193301
115852-48-7 | Propanamide, N-(1-cyano-1,2-dimethylpropyl)-2-(2,4-dichlorophenoxy)- | AA000GW2 | MFCD06798290
1159511-86-0 | 4-Bromo-2,5-dimethyl-2h-indazole | AA000H4J | MFCD12028631
115996-72-0 | Methyl 4-hydroxy-tetrahydro-2h-pyran-4-carboxylate | AA000HC7 | MFCD12031301
1190380-60-9 | 1-Methyl-1h-pyrazolo[3,4-b]pyridin-5-amine | AA000I15 | MFCD17016021
1192-30-9 | Tetrahydrofurfuryl bromide | AA000I9Y | MFCD00016894
1194-04-3 | 4-Cyano-1-methylpyridin-1-ium iodide | AA000IM8 | MFCD00031911
1195672-98-0 | 2-(1H-Pyrazol-4-yl)acetonitrile | AA000IW4 | MFCD09909624